Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Circular RNA-based Therapeutic
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Acquisition
Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy
Details : Circularis platform will give Ginkgo the ability to rapidly identify context-specific promoters for cell therapy and circular RNA-based therapeutic applications, such as those that modulate gene expression in the tumor microenvironment.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
October 04, 2022
Lead Product(s) : Circular RNA-based Therapeutic
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?